“We consider the ‘pathologist and physician-centric model’ (Medical Leadership) as the only way to achieve excellence in pathology,” emphasized Goldschmidt. “I was thrilled to discover that CPL has the exact same model and has used this model effectively to compete in the United States. “This higher level of personalized service we deliver resonates much more effectively with our number one customer-the referring physician,” observed Goldschmidt. “Unlike some of our major competitors, we have institutionalized a model that has pathologists directly involved in the management of our businesses. “Sonic’s success over the past decade has been predicated on our steadfast commitment to a concept of ‘Medical Leadership’,” he explained. “Both our companies have very similar values and philosophies. Goldschmidt, M.D., CEO and Managing Director of Sonic. “I’m particularly excited about the Sonic–CPL partnership,” stated Colin S. In fact, both CPL’s corporate culture and its management talent were major motivations for Sonic Healthcare to pursue this acquisition. CPL Management To StayĬPL, with annual revenues approaching $190 million, was paid “a prospective EBITDA multiple of approximately 9.5.” The deal is expected to close by Septemand Sonic Healthcare wants CPL’s management team to remain and continue to play an active role following the sale. Under the terms of the deal, between 20, Sonic Healthcare will purchase the remaining equity from CPL management and pathologists.
Sonic Health will pay approximately US$300 million to acquire between 80% and 85% ownership of CPL. It also owns and operates laboratories in New Zealand, Germany and the United Kingdom. Sonic Healthcare is the largest laboratory services company in Australia. Second, the sale of CPL brings a new and credible competitor into the U.S. This continues a trend of local pathologists selling their lab company to bigger firms. First, it means that local pathologists will no longer fully own and operate the nation’s largest, private lab company providing laboratory testing services to office-based physicians. The sale of CPL is a significant event for two related reasons. The announcement was made on Augand capped a lengthy bidding process for Clinical Pathology Labs (CPL). will acquire a majority interest in Clinical Pathology Laboratories, Inc. IN A TRANSACTION SURE TO ROIL the competitive lab testing marketplace, Australia-based Sonic Healthcare Ltd. market and is likely to trigger significant changes to the status quo. The acquisition brings a new lab competitor into the U.S. are selling up to 85% of their lab company to Sonic Healthcare, Ltd, Australia’s largest laboratory firm. Pathologist-owners of Austin, Texas-based Clinical Pathology Laboratories, Inc. A pathologist uses information gathered from the microscopic examination of tissue specimens, cells and body fluids, and from clinical laboratory tests on body fluids and secretions for the diagnosis, exclusion and monitoring of disease.CEO SUMMARY: It’s one of the most interesting lab acquisitions to take place in the past decade. Practices include diagnostic tests on blood, urine, sputum, feces, spinal fluid, pleural fluid, and belly fluid, as well as biopsy and autopsy.Ī pathologist deals with the causes and nature of disease and contributes to diagnosis, prognosis and treatment through knowledge gained by the laboratory application of the biologic, chemical and physical sciences. Medical tests, procedures and therapies provided by Anatomic Clinical Pathology
Significant diseases and conditions treated atĪnatomic Clinical Pathology practices include diabetes and cancer. The study of disease in bodily fluid, tissues, and organs. Laboratory tests to detect and treat the causes of illnesses. With healthcare providers who have special training and skill in determining the origin, type, and severity of a disease.Īnatomic & Clinical Pathologists at Halifax Pathology Associates, PA perform Halifax Pathology Associates, PA is an Anatomic Clinical Pathology practice in Daytona Beach, FL
0 kommentar(er)
